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tor and transporter (transceptors) for amino acids and previous
studies have shown that the availability of amino acids for the cell
inﬂuences diacetyl production. We veriﬁed the transcriptome data
by immunoblot analysis as Gap1p is known to have strong post-
translational regulation. We proposed the hypothesis that there
is a positive correlation between amounts of Gap1pand diacetyl
levels. To verify this we analysed diacetyl production under vary-
ing Gap1p levels. Diacetyl levels were examined in Δgap1 and
in Gap1p overexpression strains of S. cerevisiae and compared to
the wild type. Our results indicate that inﬂuencing Gap1p levels
indeed leads to changes in diacetyl levels. We also show a posi-
tive correlation betweenGap1p expression level and diacetyl levels
under brewing conditions using industrial yeast strains. Our results
could help towards developing a novel approach to inﬂuence
diacetyl levels and thus reducing time needed for beer maturation.
Keywords: Beer fermentation; Diacetyl; Transcriptome data;
General amino-acid permease; Protein overexpression
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Scale up of industrial enzyme production
Rogier Meulenberg
DSM Biotechnology Center, Delft, The Netherlands
Industrial fermentation R&D projects commonly start with
laboratory scale strain testing and/or fermentation process devel-
opment, later followed by transfer of selected strains and
optimized fermentation protocols to production facilities. For
important fermentation products, business demands are shifting
from maximized productivity to increased speed of successful scal-
ing up; time consuming iterations between the scales are no longer
tolerated.
One approach in preventing major mishaps in scaling up is
proper testing of the sensitivity of key performance indicators of
the fermentation process to the differences that are anticipated
between the scales. Thus, good scale down models do not only
have value in studying scale up effects, but also in business risk
reduction.
This contribution presents some experience gained in industrial
R&D practice on (absence of) scale up effects of various fermen-
tation parameters on microbial enzyme production. The results
lead to suggested improvements of the design of representative
laboratory scale fermentation experiments.
http://dx.doi.org/10.1016/j.nbt.2012.08.209
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Analysis of oxygen transport enhancement by function-
alized magnetic nanoparticles (FMP) in bioprocesses
Filipe Ataíde ∗, Cristiana Azevedo, Joao J. Clemente, Antonio E.
Cunha, Filomena Freitas, Maria A.M. Reis, Ana C.A. Roque, Rui
Oliveira
FCT-UNL, Caparica, Portugal
The central goal of this study was to develop functionalized
magnetic nanoparticles (FMP) to enhance oxygen transport in
bioprocesses. FMP were designed to possess a magnetic core and
a coating suitable to confer colloidal stability to the particles
in water dispersions. Previous studies have shown that FMP are
able to increase the oxygen mass transfer coefﬁcient by 6-fold in
Escherichia coli cultures.
Different magnetic nanoparticles with different coatings and
sizes were pre-screened in shake ﬂasks against cellular aggregation,
which needs to be prevented in cultivation conditions. In partic-
ular, FMP with silica and oleic acid coating were evaluated since
these particles are inexpensive and are currently available in the
market.
A glass 0.5-l reactor was custom manufactured for assessment
of oxygen transport enhancement due to FMP. The reactor design,
bafﬂes and Rushton impeller are of standard dimensions, namely,
wB/T=1/10,D/T=1/3.Mass transfer tests were carried out through
the use of the sulphite oxidation method, applying iodometric
back-titration.
For determination of kLa a catalyst concentration of 10−6 M
(under which there is no mass transfer enhancement by the chem-
ical reaction) was used while for the determination of interfacial
area a catalyst concentration of 10−4 M was used. The parameters
used for mass transfer runs with FMP were: 300–600 rpm for stir-
ring speed, 0.5–2.0 vvm for aeration, 0.8M of initial sodium sulﬁte
concentration and 0–4% FMP mass fraction.
http://dx.doi.org/10.1016/j.nbt.2012.08.210
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Establishing new microbial cell factories for sustainable
bioprocesses
Mhairi Workman ∗, Philippe Holt, Xiaoying Liu
Center for Microbial Biotechnology, Department of Systems Biology,
Technical University of Denmark, 2800 Kgs Lyngby, Denmark
The demands of modern society are increasing pressure on natural
resources while creating the need for a wider range of products.
There is an interest in developing bioprocesses to meet these
demands, with conversion of a variety of waste materials provid-
ing the basis for a sustainable society. The application of biological
catalysts which can convert a variety of substrates to an array of
desirable products has been demonstrated in both ancient bio-
processes and modern industrial biotechnology. In recent times,
focus has been on a limited number of “model” organisms which
have been extensively exploited and developed. Systems biol-
ogy approaches can be applied with these well studied strains,
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where considerable physiological data has been obtained, genome
sequences are known and genetic tools have been developed.
With the necessity of considering awider array of substrates and
the need for new types of products, it may be interesting to look
to less domesticated strains and towards more non-conventional
hosts in the development of new bioprocesses. This approach
demands thorough physiological characterization as well as estab-
lishment of tools for genetic engineering if new cell factories
are to be exploited through application of systems biology tools.
Here two potential cell factories for the conversion of glycerol
are described: Pachysolen tannophilus and Yarrowia lipolytica. These
organisms exhibit considerable potential; producing ethanol and
1,3-butanediol (P. tannophilus) and organic acids, lipids and poly-
ols (Y. lipolytica). In addition to their product range the strains
are also capable of converting carbon sources found in a range of
sustainable feedstocks.
http://dx.doi.org/10.1016/j.nbt.2012.08.211
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Growth characteristics determination for in vitro and
pilot-scale growth of the potential probiotic, Enterococ-
cus faecium to be used in ﬁsh aquaculturing
Haluk Hamamci, Ali Og˘uz Büyükkileci, Nihal Destan Aytekin ∗
Middle East Technical University, Ankara, Turkey
The aquaculturing of marine and fresh water ﬁsh is one of the
fastest growing sectors in the world and in Turkey. Rainbow trout
(Oncorhynchus mykiss) has the highest share in aquaculturing in
Turkey. Within the industry, especially after the antibiotic usage in
true feed is phased throughout the world, the need for enhanced
disease resistance, growth performance, feed efﬁciency has come
to order. Probiotic usage is a proved alternative, not only for help-
ing control of speciﬁc diseases, contributing to digestive systems
and development of the immune systems, but also for performing
antagonistic effect against ﬁsh pathogens by aiding the defensive
barrier of gut microbiota. The primary application in aquacultur-
ing has been to effect the composition of the aquatic medium.
In this study, optimum growth parameters for both batch
growth of potential probiotic, Enterococcus faeicum and fed-batch
growth of the microorganism were determined. In the batch stud-
ies, varying amounts of pepton, yeast extract and glucose were
tried. Whey was evaluated as an alternative carbonhydrate source
for decreasing product cost. The trials showed comparable growth
maintenance up to an OD of 8 at 600nm.
The probiotic will be maintained in a form to be fed to aqua-
cultured trouts in pilot scale and in bilateral ﬁsh farms. Also, the
antagonistic effect of the microorganism against the pathogens;
Vibrio anguillarium, Lactococcus garviae, Yersinia enterocolitica that
are isolated from rainbow trout microbiota, has been investigated
and according to pre-studies, Lactacoc is observed to be declined
at least 10 folds.
http://dx.doi.org/10.1016/j.nbt.2012.08.212
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Actinoplanes friuliensis is a rare actinomycete which produces the
highly potent lipopeptide antibiotic friulimicin. This antibiotic
is active against a broad range of multiresistant gram-positive
bacteria such as methicillin-resistant Enterococcus spec. and Staphy-
lococcus aureus (MRE, MRSA) strains [1].
In order to characterize the complex interactions of antibi-
otic metabolism in A. friuliensis, cultivations are carried out in a
bioreactor under deﬁned and controlled conditions. A chemically
deﬁned production medium, especially developed for A. friuliensis,
is used. This deﬁned medium is a prerequisite for the quantita-
tive analysis of cell metabolism during the cultivations and is also
necessary to apply a new developed middle infrared spectroscopy
method (AquaSpec Technology,micro-biolytics GmbH, Esslingen).
With this method, all known substrates and metabolites can be
measured in one sample.
For friulimicin biosynthesis by A. friuliensis some amino acids
are required as substrates. Ammonium is produced as a by-product
of amino acid metabolism. It was shown to inhibit friulimicin
biosynthesis. Therefore, fed-batch cultivation strategies are devel-
oped in order to avoid production of this by-product.
Data from cultivations are also used to develop a metabolic ﬂux
model (Insilico Biotechnology, Stuttgart) on the basis of genome
data (Cebitec, Bielefeld).
The ﬂux model, combined with data from cultivation and
transcription analysis, should give hints for directed genetic mod-
iﬁcations and optimization of process control strategies with the
objective to redirect metabolic ﬂuxes towards friulimicin produc-
tion.
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Unwanted substrate gradient in industrial-scale bioreactors prede-
termines cell’s growth in oscillating conditions. For experimental
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